Literature DB >> 11174376

Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris.

J V Schaffer1, D M Davidson, J M McNiff, J L Bolognia.   

Abstract

Minocycline is an oral antibiotic widely used for the long-term treatment of acne vulgaris. Unusual side effects of this medication include two overlapping autoimmune syndromes: drug-induced lupus and autoimmune hepatitis. In addition, in a few patients livedo reticularis or subcutaneous nodules have developed in association with arthritis and serum perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) during long-term minocycline therapy. We report the cases of two young women receiving long-term minocycline therapy (>3 years) in whom P-ANCA-positive cutaneous polyarteritis nodosa developed. Both patients presented with a violaceous reticulated pattern on the lower extremities. Histologic examination of biopsy specimens from a reticulated area and a subcutaneous nodule showed necrotizing vasculitis of medium-sized arteries in the deep dermis, consistent with the diagnosis of polyarteritis nodosa. The cutaneous lesions rapidly resolved on discontinuation of minocycline and initiation of prednisone therapy. A high index of suspicion and testing for antineutrophil cytoplasmic antibody in addition to the standard antinuclear antibody panel can facilitate diagnosis of minocycline-related autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11174376     DOI: 10.1067/mjd.2001.112218

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

Review 1.  Drug-induced vasculitis.

Authors:  Marta Lucia Cuellar
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

2.  Minocycline-induced renal polyarteritis nodosa.

Authors:  Hossein Tabriziani; Christopher S Wilcox; Olivia N Gilbert; Michael S Lipkowitz
Journal:  BMJ Case Rep       Date:  2012-08-13

3.  Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.

Authors:  Deanna L Kelly; Kelli M Sullivan; Joseph P McEvoy; Robert P McMahon; Heidi J Wehring; James M Gold; Fang Liu; Dale Warfel; Gopal Vyas; Charles M Richardson; Bernard A Fischer; William R Keller; Maju Mathew Koola; Stephanie M Feldman; Jessica C Russ; Richard S E Keefe; Jennifer Osing; Leeka Hubzin; Sharon August; Trina M Walker; Robert W Buchanan
Journal:  J Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.153

Review 4.  A Spotlight on Drug-Induced Vasculitis.

Authors:  Kinanah Yaseen; Alana Nevares; Hiromichi Tamaki
Journal:  Curr Rheumatol Rep       Date:  2022-09-21       Impact factor: 4.686

Review 5.  ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review.

Authors:  Petar Lenert; Michael Icardi; Laila Dahmoush
Journal:  Clin Rheumatol       Date:  2013-04-21       Impact factor: 2.980

6.  Lymphocytic thrombophilic arteritis induced by minocycline.

Authors:  Michael Kassardjian; David Horowitz; Paul K Shitabata; Lani E Clark
Journal:  J Clin Aesthet Dermatol       Date:  2012-10

7.  Vasculitic neuropathy following exposure to minocycline.

Authors:  John M Baratta; P James B Dyck; Patricio Brand; Pariwat Thaisetthawatkul; Peter J Dyck; JaNean K Engelstad; Brent Goodman; Chafic Karam
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-11-12

Review 8.  Remission of Angiographically Confirmed Minocycline-induced Renal Polyarteritis Nodosa: A Case Report and Literature Review.

Authors:  Kenichi Yokota; Isao Kurihara; Toshifumi Nakamura; Seishi Nakatsuka; Kazutoshi Miyashita; Sakiko Kobayashi; Ayano Murai-Takeda; Masakatsu Sone; Hiroshi Itoh
Journal:  Intern Med       Date:  2021-06-26       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.